Literature DB >> 27551249

Current Diagnosis and Management of Suspected Reflux Symptoms Refractory to Proton Pump Inhibitor Therapy.

Joel E Richter1.   

Abstract

Suspected reflux symptoms that are refractory to proton pump inhibitors (PPIs) are rapidly becoming the most common presentation of gastroesophageal reflux disease (GERD) in patients seen in gastroenterology clinics. These patients are a heterogeneous group, differing in symptom frequency and severity, PPI dosing regimens, and responses to therapy (from partial to absent). Before testing, the physician needs to question the patient carefully about PPI compliance and the timing of drug intake in relation to meals. Switching PPIs or doubling the dose is the next step, but only 20% to 25% of the group refractory to PPIs will respond. The first diagnostic test should be upper gastrointestinal endoscopy. In more than 90% of cases, the results will be normal, but persistent esophagitis may suggest pill esophagitis, eosinophilic esophagitis, or rarer diseases, such as lichen planus, Zollinger-Ellison syndrome, or genotype variants of PPI metabolism. If the endoscopy results are normal, esophageal manometry and especially reflux testing should follow. Whether patients should be tested on or off PPI therapy is controversial. Most physicians prefer to test patients off PPIs to identify whether abnormal acid reflux is even present; if it is not, PPIs can be stopped and other diagnoses sought. Testing patients on PPI therapy allows nonacid reflux to be identified, but more than 50% of patients have a normal test result, leaving the clinician with a conundrum-whether to stop PPIs or continue them because the GERD is being treated adequately. Alternative diagnoses in patients with refractory GERD and normal reflux testing include achalasia, eosinophilic esophagitis, gastroparesis, rumination, and aerophagia. However, more than 50% will be given the diagnosis of functional heartburn, a visceral hypersensitivity syndrome. Treating patients with PPI-refractory GERD-like symptoms can be difficult and frustrating. Any of the following may help: a histamine-2 receptor antagonist at night, baclofen to decrease transient lower esophageal sphincter relaxations, pain modulators, acupuncture, or hypnotherapy. At this time, antireflux surgery should be limited to patients with abnormal acid reflux defined by pH testing and a good correlation of symptoms with acid reflux.

Entities:  

Keywords:  Refractory gastroesophageal reflux disease; antireflux surgery; baclofen; pain modulators; proton pump inhibitors; proton pump inhibitor—resistant gastroesophageal reflux disease

Year:  2014        PMID: 27551249      PMCID: PMC4991531     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  69 in total

1.  Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication.

Authors:  G M Campos; J H Peters; T R DeMeester; S Oberg; P F Crookes; S Tan; S R DeMeester; J A Hagen; C G Bremner
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

Review 2.  Alternative therapeutic approaches to chronic proton pump inhibitor treatment.

Authors:  Ronnie Fass
Journal:  Clin Gastroenterol Hepatol       Date:  2011-12-16       Impact factor: 11.382

Review 3.  Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors.

Authors:  Daniel Sifrim; Frank Zerbib
Journal:  Gut       Date:  2012-06-08       Impact factor: 23.059

4.  Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication.

Authors:  I Mainie; R Tutuian; A Agrawal; D Adams; D O Castell
Journal:  Br J Surg       Date:  2006-12       Impact factor: 6.939

5.  Selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus: a randomized, double-blind, placebo-controlled study.

Authors:  Nikos Viazis; Anastasia Keyoglou; Alexandros K Kanellopoulos; George Karamanolis; John Vlachogiannakos; Konstantinos Triantafyllou; Spiros D Ladas; Dimitrios G Karamanolis
Journal:  Am J Gastroenterol       Date:  2011-05-31       Impact factor: 10.864

Review 6.  Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease.

Authors:  A Becher; H El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2011-07-20       Impact factor: 8.171

7.  Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.

Authors:  Frank Zerbib; Kafia Belhocine; Mireille Simon; Maylis Capdepont; François Mion; Stanislas Bruley des Varannes; Jean-Paul Galmiche
Journal:  Gut       Date:  2011-10-13       Impact factor: 23.059

8.  A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitis.

Authors:  Peter J Kahrilas; John Dent; Karsten Lauritsen; Peter Malfertheiner; Hans Denison; Stefan Franzén; Goran Hasselgren
Journal:  Clin Gastroenterol Hepatol       Date:  2007-10-22       Impact factor: 11.382

Review 9.  Proton pump inhibitor failure--what are the therapeutic options?

Authors:  Ronnie Fass
Journal:  Am J Gastroenterol       Date:  2009-03       Impact factor: 10.864

10.  Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully responded.

Authors:  Ram Dickman; Mona Boaz; Shoshanna Aizic; Zaza Beniashvili; Ronnie Fass; Yaron Niv
Journal:  J Neurogastroenterol Motil       Date:  2011-10-31       Impact factor: 4.924

View more
  5 in total

1.  The Spectrum of Reflux Phenotypes.

Authors:  Lisa B Mahoney; Rachel Rosen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-12

2.  The high frequency of esophageal disorders in Iranian patients with non-cardiac chest pain.

Authors:  Saeed Abdi; Roghayeh Sahraie; Habib Malekpour; Sara Ashatri; Somayeh Jahani-Sherafat; Majid Iranshahi; Mojgan Frootan
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2018

Review 3.  Laryngopharyngeal Reflux: A State-of-the-Art Algorithm Management for Primary Care Physicians.

Authors:  Jerome R Lechien; Sven Saussez; Vinciane Muls; Maria R Barillari; Carlos M Chiesa-Estomba; Stéphane Hans; Petros D Karkos
Journal:  J Clin Med       Date:  2020-11-10       Impact factor: 4.241

4.  Clinical profile and characteristics of eosinophilic esophagitis patients presenting with refractory gastroesophageal reflux disease in Makassar, Indonesia.

Authors:  Mariska Regina Kaurrany; Muhammad Amsyar Akil; Abdul Qadar Punagi; Andi Muhammad Lutfi Parewangi
Journal:  Pan Afr Med J       Date:  2022-02-02

5.  Comparison of Esophageal Function Tests in Chinese Patients with Functional Heartburn and Reflux Hypersensitivity.

Authors:  Feng Gao; Yan Gao; Xue Chen; Jie Qian; Jie Zhang
Journal:  Gastroenterol Res Pract       Date:  2017-09-06       Impact factor: 2.260

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.